It’s not ok. Some of these false and misleading statements are violations of sec rules. Be careful.

And when nothing happens with Verizon in September then what?

You’re short at $11.94? Lol. enjoy the margin calls.

His history is dismal.

It is not run by Verizon. If it were Verizon would have to include it on their balance sheet and annual reporting and they don’t.

Patients suffer and the FDA doesn’t give a shit. Nothing new to see here.

I think it makes it more difficult for PLX to obtain FDA approval as the competition is in a stronger position now.

you should be careful. did you know that a short position has unlimited loss potential? very easy to go bankrupt after margin calls.

that makes no sense.

the stock price just keeps falling. it's in a death spiral.

there are dozens of sources. Take your pick. I included a link to a source just to help you out.

25% of the float is still shorted. I'm not sure why you think you can make your arguments when the facts clearly are not on your side.

https://www.ortex.com/stocks/26195/shorts

Go RNTD

Lol. Apparently research for some people is defined as looking on the way back machine.

not really. Usually a SPAC is clean and compliant. Unlike RMTD which is bloated with a long dirty history and certainly not compliant with any current SEC requirements.

it's not a dead ticket anymore?

a bloated non-compliant non-reporting shell is not the right tool to go public. Verizon has many other better options if they wanted to do a spin-off.

Update: apparently the CRL is due to the FDA being unable to inspect the facility in Carmiel Israel. The third party facility was approved via Section 704(a)(4) of the Federal Food, Drug, and Cosmetic Act in lieu of a pre-licensing inspection.

So if I understand this correctly, the FDA delayed the decision for 3 months because they were unable to travel to Israel to inspect the facility. Then 3 months later they still didn't bother to travel to the facility and rejected the application because they were unable to do the inspection. On what planet does this make any sense?

There is also reference to Fabrazyme being converted to full approval so any new submission by PLX must be in the context of that change. I'm guessing that this means a more demanding requirement for PLX to show superiority vs. Fabrazyme?

I never saw any issues with the clinical trials. The science looks really strong. Given the opinions of experts, some of whom post regularly, as well as the FDA's acceptance of the BLA and the ongoing success of the phased trials, I would be shocked if the rejection is based on the outcome of the trials. I think it's far more likely that there are issues with the manufacturing and/or labeling. I think that would explain why the companies aren't dropping the drug. On the contrary, some patients continue to use the drug which certainly wouldn't be the case if there were any safety issues.

The red flags I have seen and been fairly vocal about on this message board is the lack of transparency and at times raw incompetence of the company's management team. The recent dilution so close to the PDUFA was a giant red flag. If management had confidence in approval they would have waited just a few months for the milestone payments, or if necessary, wait to sell more shares at a far higher stock price. Instead they rushed to sell shares prior to the approval date. I don't think this was just a lucky decision. The lack of transparency continues even today. The press release says nothing about the reasons for the rejection. Apparently they regard investors as just an annoyance. A group that provides the funding the company needs but doesn't deserve any information. This company's senior executives don't deserve to keep their jobs. If I were Chiesi I'd demand big changes and fast!

Lots of posts on Stocktwits that it will take at least a year to resubmit for approval. Does anyone know if that is true? Assuming the company can resolve the issues is the resubmission process typically 1 year or longer ?

Now we know why they diluted so close to the PDUFA date. They must have had good reason to think this could happen. I wouldn’t be surprised to see lawsuits coming.

RIP PLX

Go RNTD

That PR would send the stock price plummeting.

What’s a dead ticket? Like a ticket to a menudo concert?

A settlement in the works

Your wish is granted.

Everyone is just waiting. Volume is practically non existent.

True. Gambling has far better odds of winning than this pile of cow dung.

Nonsense. The HF’s are panicking while they watch the new rules squeezing them into a corner and they can’t escape.

You’d better start covering the 10M short position. Tell your boss.

That’s such an interesting theory for a stock that has gone from $2 to $150 in a year.

I would wait for 0.0001 and get a cool billion shares.

That’s an interesting story.

Yes. You are.

Hopefully it means they want to settle out of court

I knew about the Arclight closures but hadn’t heard about Regal Cinemas. In theory there will be significantly less competition for AMC going forward which could help with sales and ticket prices.

I’d still love to see AMC explore new revenue opportunities. A combo of big screen movies with a virtual reality component? Sort of like 3D on steroids. Or a deal with Amazon to show Prime movies, perhaps with a discount for Prime subscribers similar to discounts at Whole Foods for Prime members. Or a deal with Netflix to show unique Netflix content again with a discount for Netflix subscribers. Lots of possibilities to leverage the theater’s big screen experience. And a win/win for the partners.

What buying? Volume is pitiful. What happened to all the buyers?

This needs more volume by a factor of 50x for any chance to really spike.

Looks like you were wrong. Again.